TG THERAPEUTICS, INC. Contractual Obligation, to be Paid, Year Four and Five
TG THERAPEUTICS, INC. (TGTX) had Contractual Obligation, to be Paid, Year Four and Five of $3.74 million as of 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Notes › Commitment and Contingencies › Contractual Obligation, Fiscal Year Maturity
us-gaap:ContractualObligationDueInFourthAndFifthYear · last filed 2024-02-29
- 2023-12-31: Contractual Obligation, to be Paid, Year Four and Five $3.74M.
- 2022-12-31: Contractual Obligation, to be Paid, Year Four and Five $3.99M.
- 2021-12-31: Contractual Obligation, to be Paid, Year Four and Five $78.00M.
- 2020-12-31: Contractual Obligation, to be Paid, Year Four and Five $3.58M.
| Period end | Contractual Obligation, to be Paid, Year Four and Five |
|---|---|
| 2023-12-31 | $3.74M 10-K · filed 2024-02-29 |
| 2022-12-31 | $3.99M 10-K · filed 2023-03-01 |
| 2021-12-31 | $78.00M 10-K · filed 2022-03-01 |
| 2020-12-31 | $3.58M 10-K · filed 2021-03-01 |
| 2019-12-31 | $3.71M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |